Not Signed In - Phase II Study Of Pirfenidone In Idiopathic Pulmonary Fibrosis Patients
Tue, 03 May 2005 06:00 AM EST
... InterMune, Inc (Nasdaq: ITMN) today announced that the American Journal of Respiratory andCritical Care Medicine (AJRCCM) published results from a double-blind,randomized, placebo-controlled Phase II trial evaluating pirfenidone for thetreatment of patients with idiopathic pulmonary fibrosis (IPF)... click link for more info. ...
Related Topics
- Pulmonary Fibrosis
- Cystic Fibrosis
- Pulmonary Hypertension
- Pulmonary Embolism
- Interstitial pulmonary fibrosis
- Edema
- Chronic Obstructive Pulmonary Disease
- Clinical Trials
- Chronic Diseases
- Nystatin and Triamcinolone
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Hantavirus Pulmonary Syndrome
- Thrombocytopenia
- Fibrosis
- Kniest dysplasia
- Cardiomyopathy
email this page
print this page
bookmark this page
feedback on this page
